Loading clinical trials...
Loading clinical trials...
A Preliminary Clinical Study of TC-G203 for Patients With GPC3-Positive Recurrent/Metastatic Solid Tumors
Conditions
Interventions
TC-G203 cells treatment
Locations
2
China
Beijing Gobroad Hospital
Beijing, Beijing Municipality, China
GoBroad Healthcare Group
Beijing, Beijing Municipality, China
Start Date
December 18, 2025
Primary Completion Date
December 31, 2026
Completion Date
November 1, 2027
Last Updated
January 21, 2026
NCT07186842
NCT07493044
NCT03514368
NCT07371663
NCT07258160
NCT07161310
Lead Sponsor
Beijing GoBroad Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions